Overview
Retatrutide Overview
Retatrutide is a synthetic 39-amino-acid peptide built on a GIP-derived backbone. Its sequence contains three non-coded residues: 2-aminoisobutyric acid (Aib) at positions 2 and 20, and alpha-methyl-L-leucine at position 13. A C20 fatty diacid is attached to the lysine at position 17 through a γ-glutamic acid and AEEA linker, and the C-terminus is amidated. It first appeared in the research literature under the code LY3437943.
Retatrutide engages three class B G protein-coupled receptors in one molecule: GIPR, GLP-1R, and the glucagon receptor (GCGR). In cell-based cAMP assays, it shows the highest potency at GIPR, followed by GLP-1R and then GCGR. That makes it a useful tool for comparing receptor activation, binding affinity, and signaling bias across all three receptors in a single system. Researchers also study its lipidated side chain to understand how it shapes albumin association and stability in preclinical pharmacokinetic models.
Each lot is made by solid-phase peptide synthesis, third-party tested, and supplied with a Certificate of Analysis.
| Sequence | Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-αMeLeu-Leu-Asp-Lys-Lys(γGlu-AEEA-C20 diacid)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
|---|---|
| Sequence length | 39 amino acids |
| Also known as | LY3437943, GIP/GLP-1/glucagon receptor triple agonist |
| Molecular formula | C221H342N46O68 |
| Molecular weight | 4731.33 g/mol |
| CAS number | 2381089-83-2 |
| PubChem CID | 171390338 |
| Form | Lyophilized powder |
| Purity | >99% by HPLC, per COA |
| Storage | -20°C, sealed and protected from light |
Certificate of Analysis
| Date | Lot | Certificate |
|---|---|---|
| Retatrutide - 10mgNov 3, 2026 | 26082605 | View COA |
| Retatrutide - 40mgApr 12, 2026 | 260330RT103SP | View COA |